Speech and motor speech disorders and intelligibility in adolescents with Down syndrome.


Journal

Clinical linguistics & phonetics
ISSN: 1464-5076
Titre abrégé: Clin Linguist Phon
Pays: England
ID NLM: 8802622

Informations de publication

Date de publication:
2019
Historique:
entrez: 22 6 2019
pubmed: 22 6 2019
medline: 4 9 2020
Statut: ppublish

Résumé

The goal of this research was to assess the support for motor speech disorders as explanatory constructs to guide research and treatment of reduced intelligibility in persons with Down syndrome (DS). Participants were the 45 adolescents with DS in the prior paper who were classified into five mutually-exclusive motor speech classifications using the Speech Disorders Classification System. An ordinal index classified participants' percentage of intelligible words in conversation as High (≥ 85%), Moderate (80% - 84.9%), or Low (< 80%). Statistical analyses tested for significant differences in intelligibility status associated with demographic, intelligence, and language variables, and intelligibility status associated with motor speech classifications and speech, prosody, and voice variables. For the 10 participants who met criteria for concurrent Childhood Dysarthria and Childhood Apraxia of Speech at assessment, 80% had reduced (Moderate or Low) intelligibility and 20% had High intelligibility (significant effect size: 0.644). Proportionally more of the 32 participants who met criteria for either dysarthria or apraxia had reduced intelligibility (significant effect size: 0.318). Low intelligibility was significantly associated with across-the-board reductions in phonemic and phonetic accuracy and with inappropriate prosody and voice. Findings are interpreted as support for motor speech disorders in adolescents with DS as explanatory constructs for their reduced intelligibility. Pending cross-validation of findings in diverse samples of persons with DS, studies are needed to assess the efficacy of motor speech classification status to guide selection of treatment methods and intelligibility targets.

Identifiants

pubmed: 31221010
doi: 10.1080/02699206.2019.1595736
pmc: PMC6604063
mid: NIHMS1524511
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

790-814

Subventions

Organisme : NIDCD NIH HHS
ID : R01 DC000496
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC013547
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD024356
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090256
Pays : United States

Références

J Speech Lang Hear Res. 2000 Apr;43(2):340-50
pubmed: 10757688
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):731-6
pubmed: 11254532
J Intellect Disabil Res. 2001 Aug;45(Pt 4):308-16
pubmed: 11489052
J Intellect Disabil Res. 2001 Oct;45(Pt 5):457-64
pubmed: 11679051
BMC Med Res Methodol. 2002 Jun 17;2:8
pubmed: 12069695
Int J Lang Commun Disord. 2003 Jan-Mar;38(1):47-64
pubmed: 12569036
Child Dev. 2003 Jan-Feb;74(1):75-93
pubmed: 12625437
Am J Ment Defic. 1978 Sep;83(2):193-6
pubmed: 151508
J Acoust Soc Am. 2004 Oct;116(4 Pt 1):2338-44
pubmed: 15532664
J Speech Hear Res. 1992 Apr;35(2):259-73
pubmed: 1573866
J Acoust Soc Am. 2005 Sep;118(3 Pt 1):1636-46
pubmed: 16240823
J Speech Lang Hear Res. 2005 Oct;48(5):980-95
pubmed: 16411789
Downs Syndr Res Pract. 2006 Jul;10(1):10-22
pubmed: 16869369
Downs Syndr Res Pract. 2006 Aug;11(1):9-17
pubmed: 17048805
Ment Retard Dev Disabil Res Rev. 2007;13(1):26-35
pubmed: 17326116
Pediatr Radiol. 2008 Oct;38(10):1062-7
pubmed: 18685841
Dev Neurorehabil. 2009 Apr;12(2):66-75
pubmed: 19340659
J Speech Lang Hear Res. 2009 Aug;52(4):1048-61
pubmed: 19641081
Int J Lang Commun Disord. 2010 Jan-Feb;45(1):83-95
pubmed: 19821789
Clin Linguist Phon. 2009 Dec;23(12):926-39
pubmed: 20001308
Top Lang Disord. 2009 Apr;29(2):112-132
pubmed: 20428477
Clin Linguist Phon. 2010 Oct;24(10):825-46
pubmed: 20831379
Clin Linguist Phon. 2011 Apr;25(4):321-34
pubmed: 21091205
Otolaryngol Head Neck Surg. 2012 Jan;146(1):135-40
pubmed: 21987652
J Appl Res Intellect Disabil. 2012 Sep;25(5):414-22
pubmed: 22890942
J Speech Lang Hear Res. 2013 Feb;56(1):178-210
pubmed: 23275397
Adv Clin Exp Med. 2015 Mar-Apr;24(2):301-5
pubmed: 25931364
Dev Med Child Neurol. 2015 Nov;57(11):1049-55
pubmed: 26095920
J Speech Lang Hear Res. 2016 Jun 1;59(3):460-7
pubmed: 27299989
J Speech Lang Hear Res. 2016 Jun 1;59(3):446-59
pubmed: 27300156
Semin Speech Lang. 2016 Nov;37(4):239-251
pubmed: 27701700
Folia Phoniatr Logop. 2016;68(4):175-182
pubmed: 28118637
Int J Speech Lang Pathol. 2018 Feb;20(1):75-83
pubmed: 29124959
Am J Speech Lang Pathol. 2018 Feb 6;27(1):222-236
pubmed: 29214307
Clin Linguist Phon. 2019;33(8):679-706
pubmed: 30987467
Clin Linguist Phon. 2019;33(8):772-789
pubmed: 31221009
Clin Linguist Phon. 2019;33(8):737-756
pubmed: 31221011
Clin Linguist Phon. 2019;33(8):707-736
pubmed: 31221012
Psychol Rev. 1995 Jul;102(3):594-621
pubmed: 7624456
Percept Mot Skills. 1994 Feb;78(1):307-13
pubmed: 8177677
J Speech Hear Res. 1993 Feb;36(1):105-40
pubmed: 8450654
Neuropediatrics. 1995 Dec;26(6):310-2
pubmed: 8719746
BMJ. 1998 Apr 18;316(7139):1236-8
pubmed: 9553006
Psychol Rev. 1998 Oct;105(4):611-33
pubmed: 9830375

Auteurs

Erin M Wilson (EM)

a Speech and Feeding Disorders Laboratory , MGH Institute of Health Professions , Boston , MA , USA.

Leonard Abbeduto (L)

b MIND Institute and Department of Psychiatry and Behavioral Sciences , School of Medicine, University of California , Davis , CA , USA.

Stephen M Camarata (SM)

c Department of Hearing and Speech Sciences , Vanderbilt University , Nashville , TN , USA.

Lawrence D Shriberg (LD)

d Intellectual and Developmental Disabilities Research Center, Waisman Center , University of Wisconsin-Madison , Madison , WI , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH